| scholarly article | Q13442814 |
| MDMA | Q69488 |
| P356 | DOI | 10.1007/S00213-004-1790-1 |
| P698 | PubMed publication ID | 15064911 |
| P2093 | author name string | Kathryn A Cunningham | |
| Marcy J Bubar | |||
| Paul S Frankel | |||
| Kami M Pack | |||
| P2860 | cites work | Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. | Q51584922 |
| Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats. | Q51658998 | ||
| Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. | Q51718962 | ||
| Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum. | Q52197934 | ||
| Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | Q52249429 | ||
| Inter-animal olfactory cues in operant drug discrimination procedures in rats. | Q52295964 | ||
| Role of specific dopamine receptor subtypes in amphetamine discrimination | Q69370474 | ||
| Amphetamine discrimination: effects of dopamine receptor agonists | Q69372563 | ||
| Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat | Q69374859 | ||
| Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats | Q69974756 | ||
| Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393 | Q70307062 | ||
| Serotonin-facilitated dopamine release in vivo: pharmacological characterization | Q70661667 | ||
| Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo | Q72396411 | ||
| MDMA induced dopamine release in vivo: role of endogenous serotonin | Q73458370 | ||
| Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) | Q73705416 | ||
| Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors | Q73811419 | ||
| The duration of the effects of a single administration of dopamine antagonists on ambulatory activity and motor coordination | Q77957400 | ||
| Molecular cloning and expression of the gene for a human D1 dopamine receptor | Q24298197 | ||
| Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin | Q28143430 | ||
| Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice | Q28373098 | ||
| Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes | Q28375923 | ||
| The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system | Q31128775 | ||
| Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. | Q33871547 | ||
| 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. | Q34114593 | ||
| 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. | Q34253419 | ||
| Drug discrimination studies with MDMA and amphetamine | Q34560372 | ||
| The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). | Q35146115 | ||
| Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats | Q36823553 | ||
| The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release | Q36862351 | ||
| Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist | Q38692046 | ||
| A psychomotor stimulant theory of addiction. | Q39681407 | ||
| Dopamine receptors: molecular biology, biochemistry and behavioural aspects | Q40604994 | ||
| Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. | Q41527912 | ||
| Molecular characteristics of mammalian dopamine receptors | Q41614512 | ||
| RU 24969, a 5-HT1B/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine | Q41650232 | ||
| Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs | Q42202438 | ||
| Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. | Q42202646 | ||
| Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice | Q42203999 | ||
| Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum | Q42482728 | ||
| Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat. | Q42601368 | ||
| The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice | Q43618072 | ||
| Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors | Q43829046 | ||
| Distribution of D5 dopamine receptor mRNA in rat brain | Q44144250 | ||
| Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination | Q44385002 | ||
| A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. | Q45071429 | ||
| Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. | Q45072510 | ||
| The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. | Q48098515 | ||
| Discriminative stimulus properties of cocaine: modulation by dopamine D1 receptors in the nucleus accumbens. | Q48118591 | ||
| Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors | Q48260167 | ||
| Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography | Q48342248 | ||
| Effects of remoxipride and some related new substituted salicylamides on rat brain receptors. | Q48422126 | ||
| Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain | Q48440639 | ||
| Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. | Q48623758 | ||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 326-336 | |
| P577 | publication date | 2004-04-03 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA. | |
| P478 | volume | 173 |
| Q45342467 | Attenuation of the disruptive effects of (+/-)3,4-methylenedioxymethamphetamine and cocaine on delayed matching-to-sample performance with D1 versus D2 antagonists |
| Q30494693 | Behavioral genetic contributions to the study of addiction-related amphetamine effects |
| Q33624591 | Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration |
| Q36227275 | Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats |
| Q40157269 | Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA ('Ecstasy') Substance Use Disorder |
| Q35965775 | Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats |
| Q42598029 | Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice |
| Q45968734 | Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. |
| Q33835470 | Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats |
| Q31033315 | Ecstasy: are animal data consistent between species and can they translate to humans? |
| Q46880886 | Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects |
| Q36800689 | Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain |
| Q37149027 | MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology |
| Q34364144 | MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice |
| Q42409901 | Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation |
| Q48515862 | PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice. |
| Q34564778 | Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. |
| Q38966523 | Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms |
| Q44784005 | Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists |
| Q46587077 | Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats |
| Q35590703 | Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates |
| Q40513141 | Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine |
| Q46571097 | Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse |
| Q35754068 | The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study |
| Q34760266 | Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine |
Search more.